{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05747430",
            "orgStudyIdInfo": {
                "id": "IRX-2022-002"
            },
            "organization": {
                "fullName": "iRenix Medical, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF)",
            "officialTitle": "Randomized, Controlled, Double-Masked Study to Evaluate the Efficacy of IRX-101 in Reducing Post-Intravitreal Injection Pain and Corneal Epitheliopathy",
            "acronym": "RELIEF",
            "therapeuticArea": [
                "Ophthalmology"
            ],
            "study": "sterilizing-eye-solution-to-improve-patient-comfort-relief"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-02-22",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-08-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-02-17",
            "studyFirstSubmitQcDate": "2023-02-17",
            "studyFirstPostDateStruct": {
                "date": "2023-02-28",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-06-09",
            "lastUpdatePostDateStruct": {
                "date": "2023-06-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "iRenix Medical, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a randomized, double-masked study to evaluate the tolerability and safety of IRX-101 versus 5% povidone-iodine (PI) in subjects receiving intravitreal anti-VEGF injections. The study will be conducted in up to 15 centers in the United States (US)."
        },
        "conditionsModule": {
            "conditions": [
                "Retinal Disease"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Subjects will be randomized to IRX-101 or Providone-Iodine",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "maskingDescription": "Treatment assignment will be unknown (or masked) to the study subjects, the evaluating physician, the Sponsor and its agents (with the exception of personnel performing randomization, unmasked drug accountability study monitors, and corporate compliance staff). The treating physician will be unmasked.",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 75,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "IRX-101",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects randomized to IRX-101 will receive the investigational product, IRX-101.",
                    "interventionNames": [
                        "Drug: IRX-101"
                    ]
                },
                {
                    "label": "5% Povidone-iodine",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Subjects randomized to this arm will receive the standard of care, Providone-iodine, at a concentration of 5%.",
                    "interventionNames": [
                        "Drug: Providone-Iodine"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "IRX-101",
                    "description": "IRX-101 is a novel ocular anti-septic",
                    "armGroupLabels": [
                        "IRX-101"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Providone-Iodine",
                    "description": "5% Providone-Iodine",
                    "armGroupLabels": [
                        "5% Povidone-iodine"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Safety of new drug",
                    "description": "Safety will be measured via slit lamp and fundoscopic examinations",
                    "timeFrame": "1-hour and 1-week post-treatment"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Mean corneal fluorescein staining scores",
                    "description": "Compare mean corneal fluorescein staining scores obtained after IVT in the IRX-101 and standard of care groups; corneal staining will be obtained using the validated Oxford Corneal Staining scale of 0 (no staining) to 5 (maximal staining)",
                    "timeFrame": "Immediately following intraviteral injection"
                },
                {
                    "measure": "Patient-reported post-injection pain scores",
                    "description": "Compare mean patient-reported post-injection pain scores 1-hour post-administration; pain will be assessed using the visual analog pain scale, a validated patient-reported outcome measure (questionnaire) for assessing patient's subjective pain and discomfort",
                    "timeFrame": "1-hour post-administration"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Capable of giving informed consent\n2. Stated willingness to comply with all study procedures and availability for the duration of the study\n3. Male or female, \u2265 18 years of age and receiving intravitreal anti-VEGF injections in one or both eyes\n\nExclusion Criteria:\n\n1. Current or past diagnosis of endophthalmitis\n2. Current diagnosis of uveitis\n3. Monocular patients (vision 20/100 or worse in one eye) who are receiving injections in the better seeing eye\n4. Current use of viscous lidocaine products for ocular anesthesia prior to IVT\n5. Currently receiving intravitreal steroid injections\n6. Concurrent participation in another clinical trial\n7. Females who are pregnant, planning to become pregnant or lactating",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Stephen Smith, MD",
                    "role": "CONTACT",
                    "phone": "650-785-1316",
                    "email": "stephen@irenix.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Stephen Smith, MD",
                    "affiliation": "Founder",
                    "role": "STUDY_CHAIR"
                }
            ],
            "locations": [
                {
                    "facility": "Edward Wood, MD",
                    "status": "RECRUITING",
                    "city": "Round Rock",
                    "state": "Texas",
                    "zip": "78681",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Daniel Dixon",
                            "role": "CONTACT",
                            "phone": "512-451-0103"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.50826,
                        "lon": -97.6789
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000012164",
                    "term": "Retinal Diseases"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                },
                {
                    "id": "M14999",
                    "name": "Retinal Diseases",
                    "asFound": "Retinal Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M12814",
                    "name": "Ophthalmic Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M10488",
                    "name": "Iodine",
                    "relevance": "LOW"
                },
                {
                    "id": "M229695",
                    "name": "Cadexomer iodine",
                    "relevance": "LOW"
                },
                {
                    "id": "M14088",
                    "name": "Povidone-Iodine",
                    "relevance": "LOW"
                },
                {
                    "id": "M14087",
                    "name": "Povidone",
                    "relevance": "LOW"
                },
                {
                    "id": "M4215",
                    "name": "Anti-Infective Agents, Local",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "BlSubst",
                    "name": "Blood Substitutes"
                }
            ]
        }
    },
    "hasResults": false
}